#1GLASS HOUSE BRANDS NEO GLAS.A.U OTCQX: GLAS. F Q3 2022 INVESTOR PRESENTATION#2DISCLAIMERS Cautionary Statements This document is for information purposes only and should not be considered a recommendation to purchase, sell or hold a security. This presentation has been prepared for discussion purposes only and is not, and in no circumstances is to be construed as an advertisement, public offering, or prospectus related to the securities of Glass House Brands Inc. (the "Company" or "GHB") in any jurisdiction. No securities commission or similar authority in Canada, the United States or elsewhere has reviewed or in any way passed upon this presentation or the merits thereof and any representation to the contrary is an offence. This presentation also contains or references certain market, industry and peer group data which is based upon information from independent industry publications, market research, analyst reports and surveys and other publicly available sources. Any third-party information has not been independently verified. While the Company may not have verified the third-party information, they believe that it obtained the information from reliable sources and have no reason to believe it is not accurate in all material respects. No warranties or representations can be made as to the origin, validity, accuracy, completeness, currency or reliability of the information. The Company disclaims and excludes all liability (to the maximum extent permitted by law), for losses, claims, damages, demands, costs and expenses of whatever nature arising in any way out of or in connection with the information in this presentation, its accuracy, completeness or by reason of reliance by any person on any of it including, without limitation, the choice of comparable companies, or any information related thereto. This presentation should not be construed as legal, financial or tax advice to any investor, as each investor's circumstances are different. Readers should consult with their own professional advisors regarding their particular circumstances. In making an investment decision, investors should not rely solely on the information contained in this presentation. Neither the delivery of this presentation, at any time, nor any trade in securities made in reliance on this presentation, will imply that the information contained in the presentation is correct as of any time subsequent to the date set forth on the cover page of the presentation or the date at which such information is expressed to be stated, as applicable. Investing in securities of the Company involves risks. See "Risk Factors" included in our Q3 2022 Management's Discussion and Analysis and in the Company's Annual Information Form and other public filings on SEDAR at www.sedar.com (the "Risk Factors"). This presentation does not constitute an offer to sell or the solicitation of an offer to buy any securities. All financial information is in U.S. dollars, unless otherwise indicated. Forward Looking Information Certain information set forth in this presentation and any other information that may be furnished to prospective investors by the Company in connection therewith, other than statements of historical fact, may be considered "forward-looking statements" and "forward-looking information" within the meaning of applicable Canadian securities legislation (referred to herein as forward-looking statements). Forward-looking statements include but are not limited to statements related to activities, events or developments that the Company expects or anticipates will or may occur in the future, statements related to the Corporation's business strategy objectives and goals, and the Corporation's management's assessment of future plans and operations which are based on management's current internal expectations, estimates, projections, assumptions and beliefs, which may prove to be incorrect. Forward-looking statements can often be identified by the use of words such as "may", "will", "could", "would", "should", "anticipate", "believe", "expect", "intend", "potential", "estimate", "budget", "scheduled", "plans", "planned", "forecasts", "goals" and similar expressions or the negatives thereof. In particular, and without limiting the generality of the foregoing, forward looking statements in this presentation include statements related to the buildout and development of the cultivation facility owned by the Company in Camarillo, California (referred to herein as the SoCal Farm); the Company's business plans and strategies; the addressable markets for the Company's products; the Company's competitive position,; the ability to develop products, scale production and distribute productsh; the Company's retail expansion strategy and plans to grow its market share in existing and new markets; the Company's investment in new technologies and products; the Company's expansion of production capacity; the development and expansion of the Company's brands; strategic acquisition opportunities; the future size of the cannabis market in California and the United States; the receipt of licenses from regulatory authorities; and the Company's future financial performance. In addition, the financial projections and estimates contained under "Pro Forma Wholesale Biomass Economics" and elsewhere in this presentation, including proforma gross profit and gross profit margin constitute "forward looking information" within the meaning of applicable securities laws. Such information is being provided to demonstrate potential future outcomes and may not be appropriate for other purposes and should not be relied upon as necessarily being indicative of future financial results. Forward looking statements involve known and unknown risks and uncertainties, many of which are beyond our control, that could cause actual results to differ materially from those that are disclosed in or implied by such forward looking statements. These risks and uncertainties include, but are not limited to, those described in the Risk Factors and the other risk factors identified in this presentation. Although the Company has attempted to identify the main risk factors that could cause actual results to differ materially from those contained in forward looking statements, there may be other risk factors not presently known to the Company or that they presently believe are not material that could also cause actual results or future events to differ materially from those expressed in such forward-looking information. Although the forward-looking statements contained in this presentation are based upon what the Company believes are reasonable assumptions, you are cautioned against placing undue reliance on these statements since actual results may vary from the forward-looking statements. Any data demonstrating the historical performance contained in this presentation are intended only to illustrate past performance and are not necessarily indicative of the future performance of the Company. Consequently, all of the forward-looking statements contained in this presentation are qualified by the foregoing cautionary statements, and there can be no guarantee that the results or developments that the Company anticipate will be realized or, even if substantially realized, that they will have the expected consequences or effects on our business, financial condition or results of operation. Non-GAAP Measures This presentation makes reference to certain non-U.S. GAAP measures, such as proforma gross profit and gross profit margin, among other non-GAAP measures that may be identified herein. These measures are not recognized under U.S. GAAP and do not have a standardized meaning prescribed by U.S. GAAP. Rather, these measures are provided as additional information to complement U.S. GAAP measures by providing further understanding of GH Group's results of operations from management's perspective. Market participants frequently use non-U.S. GAAP measures in the evaluation of issuers. The Company's management uses these non-GAAP measures for trend analyses and for budgeting and planning purposes. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating projected operating results and trends in and in comparing the Company's financial measures with other similar companies, many of which present similar non-GAAP financial measures to investors. Management of the Company do not consider these non-GAAP measures in isolation or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations as they reflect the exercises of judgments by management about which expense and income are excluded or included in determining these non-GAAP financial measures. You should review the Company's current financial statements and not rely on any single financial measure to evaluate the Company's business. Readers are also referred to the heading "Non-GAAP Financial Measures" in the Company's Q3 2022 MD&A at www.Sedar.com. Cannabis-related Activities are Illegal Under U.S. Federal Laws The Company derives 100% of its revenues from doing business in the cannabis industry in the U.S. The concepts of "medical cannabis" and "adult-use cannabis" do not exist under U.S. federal law. The U.S. Federal Controlled Substances Act classifies "marihuana" as a Schedule I drug. Accordingly, cannabis- related practices or activities, including, without limitation, the manufacture, sale, importation, possession, use or distribution of cannabis and its derivatives, are illegal under U.S. federal law and the enforcement of the relevant laws poses a significant risk. These laws and their enforcement are in flux and vary dramatically from jurisdiction to jurisdiction. The enforcement of these laws and its effect on the Company and its business, employees, directors and shareholders are uncertain, and accordingly, involve considerable risk. Strict compliance with state laws with respect to cannabis will neither absolve the Company of liability under U.S. federal law, nor will it provide a defense to any federal proceeding which may be brought against the Company. Any such proceedings brought against the Company may adversely affect the Company's operations and financial performance. 2#3ACHIEVEMENTS WE LISTED IN JUNE 2021, WHAT HAVE WE ACCOMPLISHED SINCE? Acquired the SoCal Farm for $93m in cash, a $25m discount from the originally agreed price, in September 2021. Total consideration, including cash, share compensation and earnout contingencies was valued at $157 million at end Q3 2021 ❖ Secured $100m in Financing from Whitehawk for SoCal Farm capex in December 2021 SoCal Farm licenses acquired by March 2022, first harvest in late May, first sale in late June - all ahead of schedule Acquired PLUS Gummies - a top five California edibles brand - in April 2022 Started with 3 Dispensaries, have 7 now, aim to have 10 by year-end 2022 ✰ Glass House's potential cultivation footprint is substantially larger than that of many top MSOs, and it is concentrated in only 3 farms all located in the world's best growing climate The California market may be tough, but like training at altitude produces championship performances, we believe the national winners will come out of California AS A RESULT OF THIS ACTIVITY, GLASS HOUSE IS POISED TO ACHIEVE APPROXIMATELY 25% REVENUE GROWTH IN 2022, AND TO MORE THAN DOUBLE OUR REVENUES IN 2023 VERSUS 2021. WE ARE ALSO ON A PATH TO ACHIEVE FREE CASH FLOW POSITIVE OPERATIONS EX-CAMARILLO EXPANSION CAPEX BY Q3 2023. 3#4INVESTMENT HIGHLIGHTS LARGEST CULTIVATION FOOTPRINT, UNMATCHED CAPACITY UP TO 6 M SQ. FT. OF BEST-IN- CLASS CULTIVATION FACILITIES A BRAND BUILDING MACHINE IN THE # 1 US MARKET HIGH QUALITY, SUN-GROWN CANNABIS AT SCALE AND PREDICTABLE SUPPLY CAPABILITY SUPPORT THE SUCCESS OF OUR BRANDED PRODUCTS CALL OPTION ON INTERSTATE COMMERCE STRONGLY POSITIONED TO CARRY LEADING MARKET SHARE AND COST ADVANTAGE NATIONWIDE COMPELLING COST STRUCTURE 100% OWNED CULTIVATION ASSETS; STATE-OF-THE ART AND GEOGRAPHICALLY CONCENTRATED DEVELOPING THE LARGEST RETAIL, DELIVERY AND DISTRIBUTION NETWORK STRONG ACCESS TO CUSTOMER TOUCH AND SHELF SPACE TO DRIVE BRAND AWARENESS AND PLACEMENT TOP ESG PLAY IN CALIFORNIA CANNABIS 95% LOWER CO2 EMISSIONS AND ENERGY USE THAN THE AVERAGE INDOOR GROW 4#5GLASS HOUSE BRANDS # 1 CANNABIS COMPANY IN THE # 1 MARKET IN THE WORLD MISSION BECOME THE LARGEST AND MOST PROFITABLE VERTICALLY-INTEGRATED CANNABIS COMPANY IN CALIFORNIA, DELIVERING BRANDS TO CONSUMERS ACROSS ALL SEGMENTS 5#6CALIFORNIA: HIGH GROWTH & CONSOLIDATION POTENTIAL 30 M ADULTS 1 > 210 M TOURISTS 2 > 7,300 CULTIVATORS 3 > 1,400 DISTRIBUTORS 3 >1,550 RETAILERS 3 R > 1,450 BRANDS 4 1. Source: https://www.census.gov/quickfacts/CA 2. Source: https://industry.visitcalifornia.com/research/travel-forecast 3. Source: California Department of Cannabis Control Website, as of end November 2022. 4. Headset, the number of brands with sales during the 3-month period September 2022 to November 2022. 6#72025e Market Size Projection (Legal, $B) 7.8 CALIFORNIA: LARGEST SINGLE US CANNABIS MARKET 2021a Market Size $5.8B (Legal)* California Florida THE LEGAL MARKET IN I S MORE CALIFORNIA THAN TWICE THE SIZE OF THE NEXT BIGGEST MARKET; ALMOST A S LARGE A S THREE COMBINED THE NEXT STATES 3.2 2.9 2.8 2.5 2.4 2.2 1.9 1.7 1.7 1.6 1.6 New York Arizona Source: Headset forecast for 2025 US Market Forecasts, as of February 2022 * California Department of Tax and Fee Administration, Legal Cannabis Retail Revenues for 2021 Illinois Michigan Colorado Pennsylvania Washington Massachusetts Ohio New Jersey Oregon THE ILLEGAL MARKET I N CALIFORNIA I S ESTIMATED TO BE 2 X 3 X THE SIZE OF THE LEGAL MARKET, REPRESENTING HUGE POTENTIAL UPSIDE FOR LEGAL BRANDS A S MORE AND MORE COUNTIES LEGALIZE DISPENSARIES IN THEIR JURISDICTIONS 1.4 1.3 1.3 1.1 Virginia Oklahoma Nevada 7#8THE VERTICAL ADVANTAGE Increased cultivation utilization Increased brand sales " ☐ Increased wholesale CP G 1. Glass House announced the closing of the Grover Beach and Lemoore dispensary acquisitions on 7 Sep 2022 and the closing of the Morro Bay dispensary acquisition on 15 Sep 2022. The Turlock acquisition is projected to close in Q4 2022, shortly after the store opens. See Disclaimer on Slide 2. For more detail, see here. 2. Acquired the remaining equity ownership interests of The Pottery on July 28th, 2022. For more detail, see here. 3. The Company expects the Santa Ynez and Isla Vista dispensaries to open in Q4 2022. The Eureka dispensary is temporarily on Hold due to market conditions. See Disclaimer on Slide 2. D Owned stores NEW DISPENSARIES • NHC Grover Beach, • • Lemoore, Morro Bay & Turlock 1 The Pottery 2 Farmacy: Santa Ynez, Isla Vista & Eureka³ 8#9UNMATCHED CAPACITY AND RAPIDLY EXPANDING RETAIL FOOTPRINT Eureka Cultivation facility Berkeley Turlock Manufacturing Existing Wholly-owned Retail (7) New Retail (4) Lemoore LOMPOC MANUFACTURING License Type 6,7 & 11 PLUS & Allswell Edibles/Gummies Three locations open at listing in June 2021, seven open at the end of Q3 and ten projected by the end of 2022 • • Three existing NHC dispensaries in Grover Beach, Lemoore and Morro Bay, one more to open in Q4 in Turlock1 Farmacy Isla Vista and Santa Ynez dispensaries projected to open in Q4.2 Actively seeking other new retail locations via M&A. Morro Bay Grover Beach Santa Ynez Isla Vista Santa Barbara The Pottery: (Los Angeles) 2 Santa Ana PADARO: 350,000 sq. ft. CASITAS: 150,000 sq. ft. SOCAL: 5,500,000 sq. ft. 1. Glass House announced the closing of the Grover Beach and Lemoore dispensary acquisitions on 7 Sep 2022 and the closing of the Morro Bay dispensary acquisition on 15 Sep 2022. The Turlock acquisition is projected to close in Q4 2022, shortly after the store opens. See Disclaimer on Slide 2. For more detail, please see here. 2. The Company expects the Santa Ynez and Isla Vista dispensaries to open in Q4 2022. The Eureka dispensary is temporarily on Hold due to market conditions. See Disclaimer on Slide 2. 9#10DRAMATIC EXPANSION IN REVENUES ALREADY UNDERWAY BUILDING BLOCKS TO EXCEED $160 M RUN RATE BY 2023 ARE FALLING INTO PLACE 1 $M 70 60 50 40 30 5 22 20 10 Retail Waterfall $M CPG Waterfall 40 38 35 30 26 25 20 (3) 15 10 5 2021A 2022E Incremental 2023 Incremental Retail: Projected $43m in new revenues from NHC, new Farmacy locations and The Pottery by 2023 versus 2021 $M 70 Wholesale Biomass Waterfall 12 60 NWU 50 18 40 30 22 20 10 2021A 2022E Incremental 2023 Incremental CPG: Full year of PLUS, PLUS Relaunch, Allswell Launch and improved pricing from improved strain selection/elimination inventory overhang to drive 2023 growth of 2021A 20 2022E Incremental 2023 Incremental Wholesale Biomass: SoCal Phase I output in 2H22 drove growth this year. In 2023, revenues benefit from having SoCal Phase I production all year long 1. Company has the potential to achieve monthly revenues that annualize to $160 million. The statement assumes the following in potential revenues from each source: 1) Annualized wholesale biomass sales of $60 million; 2) Annualized retail revenues of $65 million; 3) Annualized wholesale CPG revenues of $35 million. 10 10#11FUNCTIONAL. FLAVORFUL. CANNABIS EDIBLES. STRONG BRANDS ACROSS ALL SEGMENTS GLASS HOUSE EXISTING BRANDS COVER >70% OF CANNABIS CATEGORIES GOOD. HONEST. CANNABIS. GLASS HOUSE SMALL PLUS 511 sleep CLOUDBERRY FARMS allswell B SWEET SMALLS SMALLS allswell allswell BERRY DREAM B SMALLS FIELD FIELD PLUS 1moa 2mm 3m ACTING DUAL coursing sleep LYCHEE CA 10/11/30 CA PLES FIELD ff HYPE UP ENERGY + MOTIVATION allswell Indica FIELD MAMA SUE by Sue Taylor allswell TURN ON INTIMACY + CONNECTION ZONE IN FOCUS PRODUCTIVITY SAY HELLO Relief Relief Sleep bella thorne Relief A CHILL OUT SLEEP + RELAXATION#12CONSISTENT PERFORMANCE IN FLOWER DOLLAR SHARE 3.50% BY Q4 22 OUR FIRST BRAND REACHED THE #1 FLOWER RANKING IN BDSA & #2 RANKING IN HEADSET ANALYTICS AND HAS SINCE DEMONSTRATED STEADINESS IN A VOLATILE AND COMPETITIVE MARKET 3.00% 2.50% % Market Share of 2.00% Flower Segment, by $ 1.50% #38 1.00% #110 0.50% #244 0.00% Q1 20 Q2 '20 Source: Headset + BDS Analytics, Q1 2020 thru Q3 2022 #100 Q3'20 #57 #11 Q4'20 #2 #1 #4 #4 #3 #5 #5 #5 #7 Q1'21 Q2 '21 GHF % Share (Headset). Q3 '21 GHF % Share (BDS) Q4'21 #2 42 #2 Q1'22 #1 Q2'22 GLASS #2 #2 脚 #4 #6 HOUSE FARMS Q3'22 12#13OPERATIONS: THE SOCAL GREENHOUSE 5.5M SQ. FT. OF HIGH-TECH, BEST-IN-CLASS, CONTROLLED ENVIRONMENT GREENHOUSES 20 ACRES OF SUPPLEMENTAL LIGHT: INDOOR QUALITY AT CLOSE-TO-OUTDOOR COSTS UNMATCHED CAPACITY & LOW-COST PRODUCTION 13#14OPERATIONS: EXPANDING FOOTPRINT NEW, UNMATCHED CAPACITY • 165-acre property in Southern • California (SoCAL) Planned 5.5M sq ft of cultivation across 6 state-of-the-art greenhouses to be built out in 3 Phases. 1.7M dry pounds of cannabis per annum after full greenhouse conversion Phase 2: +1.7M SQ FT (2 greenhouses) 1 Phase 1: +1.5M SQ FT (1 nursery and 1 greenhouse, retrofit commenced in 2H 2021)1 1. Graphic components showing future potential is forward looking information, see Disclaimers on Slide 2, and assumes sufficient capital for conversion, the availability of additional licenses, and supporting market conditions SOCAL 2024 3.7M SQ FT SOCAL 2022 2.0M SQ FT PADARO 2020 Q4 2020: 350,000 sq ft Q3 2020: 280,000 sq ft Q2 2020: 210,000 sq ft Q1 2020: 140,000 sq ft 500K SQ FT CASITAS 2017 Q4 2017: 150,0000 sq ft Q3 2017: 100,000 sq ft Q2 2017: 50,000 sq ft 150K SQ FT Cumulative SQ FT 14#15OPERATIONS: UNMATCHED COST STRUCTURE PRO FORMA WHOLESALE BIOMASS ECONOMICS 1 Declining cost of production leads to improving gross margins, even with difficult market conditions $ /Lb. Cost of Production² $400 $350 $300 $250 Cultivation Proforma Economics $400 $ Weighted Avg. Selling Price4 $350 70% $188 $237 $204 $204 $300 50% $250 51% $200 $ /Lb. $200 34% 30% 33% A $150 $150 $100 $50 $- Q1 Q2 22 10% $100 $238 $158 $134 $100 $50 -10% $- $(50) 3 Q3 Q4 Long-Term Goal 2021 2022 -27% -30% Q1 Q2 Q3 5 Cost of Production Proforma Gross Margin Long-Term Go al Proforma Gross Margin % 6 1. This table includes forward-looking information that is disclosed using non-GAAP measures. These non-GAAP measures are described in the notes below. For more information on non-GAAP measures and forward-looking statements, please see Disclaimers on Slide 2. 2. Cost of Production includes all expenses from nursery and cultivation to curing and trimming at which point the product is ready for sale as wholesale cannabis or to be transferred to CPG. 3. Cost of Production for Q4 2022 is based on the guidance of $135/lb provided in our Q3 Earnings Release. For more information, please see https://ir.glasshousebrands.com/release/?Glass-House-Brands-Reports-Third-Quarter-2022-Financial-Results-id-122545 4. Weighted Average Selling Price = the individual selling price for flower, smalls and trim multiplied by the mix of product for each product sold. Q3 2022 weighted average selling price of $204/pound is used for proforma Gross Margin calculation for 'Long Term Goal'. 5. Proforma Gross Profit = Weighted Average Selling Price minus Cost of Production. 6. Proforma Gross Profit Margin = Proforma Gross Profit divided by Weighted Average Selling Price 7. The purpose of this financial analysis is to provide investors with a basis for analysis of the Company's proforma cost structure. Readers are cautioned that the information may not be appropriate for other purposes. 15#16EXISTING RETAIL AT YEAR-END 2021 128 DELIVERY THE FARMACY - SANTA BARBARA Voted Best Local Dispensary 2020 and 2021 THE FARMACY - SANTA ANA Top 11 Coolest Dispensaries - Venue Report PEMACY THE FARMACY - BERKELEY Best Delivery East Bay 2021 16#17NEW RETAIL- NATURAL HEALING CENTER GROVER BEACH1 0000 1. 2. Glass House announced the closing of the Grover Beach and Lemoore dispensary acquisitions on 7 Sep 2022 and the closing of the Morro Bay dispensary acquisition on 15 Sep 2022. The Turlock acquisition is projected to close in Q4 2022, shortly after the store opens. See Disclaimer on Slide 2. For more detail, see here. Rendering of Proposed Improvement Plan. MORRO BAY1 nhe NEW LICENSE IN STANISLAUS COUNTY TURLOCK1,2 LEMOORE1 nhe 17#18NEW RETAIL FARMACY AND THE POTTERY NEW LICENSES IN SANTA BARBARA COUNTY THE FARMACY ISLA VISTA1,2 FARMAC THE FARMACY SANTA YNEZ1.2 FARMACY NEW LICENSE IN HUMBOLDT COUNTY THE FARMACY EUREKA1,2 Listed THE POTTERY - LOS ANGELES 3 Cited by Thrillist, Angeleno and the L.A. Times as one of the Best High-End Dispensaries in Southern California 1. The Company expects the Santa Ynez and Isla Vista dispensaries to open in Q4 2022, pending final land use permits and state licenses. The Eureka dispensary is temporarily on Hold due to market conditions. See Disclaimers on Slide 2. 2. Rendering of Proposed Improvement Plan. 3. Acquired the remaining equity ownership interests of The Pottery on July 28th, 2022. For more detail, see here. 18#19ESG AS A STRATEGIC AND COMPETITIVE ADVANTAGE • • STRATEGICALLY LOCATED IN CALIFORNIA, WHERE GROWING CONDITIONS ARE OPTIMAL FOCUS ON ENERGY EFFICIENCY WITH SOLAR AND COGENERATION CAPABILITIES • ESG MANDATED U.S. AUM ARE FORECAST TO REACH $53 TRILLION BY 20251 Kg CO2 per kg Flower² kWh per Sq. Ft. of Flower² 3000 300 2500 250 95% 2000 200 less CO2 emissions than 1500 150 the average indoor grower 1000 100 500 50 0 0 Avg. Indoor Avg. CA Greenhouse GHB Avg. Indoor Avg. CA Greenhouse 1. Bloomberg: https://www.bloomberg.com/professional/blog/esg-assets-may-hit-53-trillion-by-2025-a-third-of-global-aum/ 2. Seinergy July-2021, GHB commissioned study 95% less energy CANNABIS & TECH CH TODAY Ct PAWARDS DERWARD today SUSTAINABLE LE use than the average indoor grower GHB SUSTAINABLE LEADERSHIP AWARD WINNER 2020: Stewardship 2021: Energy 19#20MEET THE GLASS HOUSE TEAM KYLE KAZAN Co-founder, Chairman & CEO GRAHAM FARRAR Co-founder, President & Board Director MARK VENDETTI Chief Financial Officer HILAL TABSH Chief Revenue Officer JOHN BRE BECK BEN VASQUEZ JENNIFER BARRY GERRIT VANDERKOOY VP Investor Relations VP Farm Operations VP Retail VP Cultivation BEN VEGA General Counsel & Corporate Secretary JACQUELINE DE GINESTET VP Sales TONY HELF VP Supply Chain & Operations 20#21CAP TABLE (QUARTER-END Q3 2022) Equity Table (000's) Q3 Q2 Change Comments Total Equity Shares 66,505 59,860 6,645 Warrants Series B Series A SPAC Total Warrants 8,445 2,656 4,929 8,445 (2,273) 30,665 30,665 41,766 35,593 6,173 6.1 million shares due to acquisitions, the balance due to conversion of stock options, RSU's, and purchase adjustment - Exercise price of $5.00 with an expiration date of August 2027 Exercise price of $10.00 with an expiration date of June 2024 Exercise price of $11.50 with an expiration date of June 2026 Stock Options & RSUs Stock Options 1,565 1,634 (69) Exercise Price between $2.26 and $4.60 with expiration dates from October 2024 to October 2026 RSU's 3,541 3,745 (204) Up to 3-year vesting through 2025 Total Stock Options & RSUs 5,106 5,379 (273) 21#22GLASS HOUSE BRANDS APPENDIX#23BOARD OF DIRECTORS KYLE KAZAN • • . GRAHAM FARRAR Co-founder, Chairman & CEO of Glass House Group 30+ years of successful Private Equity & investment experience with focus on real estate Launched 23 PE funds, over $2.75B current value owned & managed properties Joined cannabis industry in 2016, co-founding what would become Glass House Group Former law enforcement officer & special ed teacher Frequent guest professor in business; graduate of and former varsity basketball player for USC Co-founder, President & Board Director of Glass House Group 20+ years of serial entrepreneurship, including taking two companies public Part of original/founding teams at Software.com, Sonos, & iStory Time Inc. (zuuka) Joined cannabis industry by founding Elite Garden Wholesale, an ag-tech hydroponics supply company Board member of Seacology, Heal the Ocean, and Santa Barbara Bowl Foundation JAMIE MENDOLA Head of Strategy and M&A at Mercer Park LP and AYR Wellness 20 years of experience as a private and public equity investor Founder and CEO of Pacific Grove Capital, a long-short hedge fund that also launched one of the earliest dedicated SPAC funds in the United States Former Partner at Scout Capital, a $7B hedge fund Previous experience at J.P. Morgan, JLL Partners, and Watershed Capital B.S. from Binghamton University and 4-year baseball letterman; M.B.A. from Stanford's Graduate School of Business . HUMBLE LUKANGA Founder of Life Line Financial Group, premiere wealth management firm servicing some of the best-known performers & leaders in business, sports & entertainment Trustee of the University of New Mexico; Board Director for several companies & foundations B.A. & M.B.A. University of New Mexico; certified CFP; UCLA Personal Finance Planning degree Named to The Hollywood Reporter's Top Business Managers list for 3 years running; New Mexico Business Weekly's "Top 40 Under 40" 23#24BOARD OF DIRECTORS (CONT'D) JOCELYN ROSENWALD HECTOR DE LA TORRE • Co-founder and Board Director of Glass House Group Veteran of real estate investment industry; most recently, successfully managed $500M portfolio Since 2016, supervised operations of the 4 funds that would become Glass House Group B.A. University of Pennsylvania; M.A. in Education, Hunter College; M.B.A UCLA Anderson School of Business Teach for America alumna, founding teacher at KIPP Star Elementary School . Member of California State Assembly representing L.A. 2004-2010; member of South Gate City Council for 8 years, including 2 as Mayor Current Chair of L.A. Care, the largest public health plan in U.S.; Trustee of Occidental College; former Executive Director of national nonprofit Transamerica Center for Health Studies Former Chair of state Budget Subcommittee on Health & Human Services, Rules Committee, and Accountability & Administrative Review Committee, among others Assembly-Appointed Member of California Air Resources Board since 2011, with focus on goods movement, the environment and green tech Graduate of Occidental College; graduate work at the Elliott School of International Affairs at the George Washington University Early, vocal advocate for cannabis policy reform GEORGE RAVELING BOB HOBAN First African American basketball coach in the Pac-8 (now Pac-12); head coach at Washington State, University of Iowa, & USC; assistant coach of medal-winning 1984 and 1988 US Olympic teams Nike's former Director of International Basketball; former commentator for Fox Sports & CBS Inducted into Naismith Memorial Basketball Hall of Fame, National Collegiate Hall of Fame; recipient of John W. Bunn Lifetime Achievement Award Author of two books; co-founder (w/Michael Lombardi) of The Daily Coach leadership program B.S. in Economics from Villanova University, where he is also in the Villanova Hall of Fame 12-year veteran of the cannabis industry and Founder of Hoban Law Group, a leading global full-service commercial cannabis law firm and the first of its kind Co-Founder of Gateway Proven Strategies, a leading global cannabis industry consulting firm Has founded, created, bought, and sold over 15 of his own cannabis companies Crafted cannabis policy solutions for over 30 countries Widely recognized by a variety of publications and organizations as one of the most influential people in the global cannabis industry 24#25GLASS HOUSE BRANDS NEO GLAS.A.U OTCQX: GLAS.F